பிரமல் பார்மா வரையறுக்கப்பட்டவை தீர்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Piramal Pharma provides sterile fill/finish services to Canadian firm

Piramal Pharma provides sterile fill/finish services to Canadian firm Piramal Pharma provides sterile fill/finish services to Canadian firm 27 January 2021 | News Source credit: Shutterstock Piramal Pharma Limited s Pharma Solutions business, a leading contract development and manufacturing organisation (CDMO), has announced that it is providing Canada based Theratechnologies Inc with GMP manufacturing of sterile fill/finish drug product to support their developmental product as it enters into a first-in-human clinical study. The clinical material is being produced at the Piramal Pharma Solutions (PPS) manufacturing site in Lexington, Kentucky, which is recognised globally for its expertise in sterile fill/finish services. It will be used in a Phase I trial for TH1902, Theratechnologies lead peptide-drug conjugate (PDC) (docetaxel conjugate).

United statesPeter deyoungPiramal pharma solutionsPiramal pharma limited solutionsTheratechnologies incPiramal pharma limitedPharma solutionsChief executive officerஒன்றுபட்டது மாநிலங்களில்பீட்டர் டியூன்பிரமல் பார்மா தீர்வுகள்பிரமல் பார்மா வரையறுக்கப்பட்டவை தீர்வுகள்பிரமல் பார்மா வரையறுக்கப்பட்டவைபார்மா தீர்வுகள்தலைமை நிர்வாகி அதிகாரி

Piramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc for TH1902 Peptide-drug Conjugate

Share this article Share this article - Piramal Pharma Solutions (PPS) is providing drug product formulation and manufacturing from the company s Lexington, KY site in the U.S. - Drug product material will be used in a first-in-humans clinical study MUMBAI, India, Jan. 25, 2021 /PRNewswire/ Piramal Pharma Limited s Pharma Solutions business, a leading contract development and manufacturing organization (CDMO), today announced that it is providing Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) with GMP manufacturing of sterile fill/finish drug product to support their developmental product as it enters into a first-in-humans clinical study. The clinical material is being produced at the Piramal Pharma Solutions (PPS) manufacturing site in Lexington, Kentucky, which is recognized globally for its expertise in sterile fill/finish services. It will be used in a Phase I trial for TH1902, Theratechnologies lead peptide-drug conjugate (PDC) (docetaxel conjugate). The Phase I tr

United statesPeter deyoungPiramal pharmaContract developmentPiramal pharma limited solutionsPiramal pharma limitedManufacturing organizationCarlyle groupPiramal pharma solutionsTheratechnologies incPiramal enterprisesPharma solutionsChief executive officerNorth americaSocial mediaPharma limited

Piramal Pharma Limited Expands Riverview, Michigan, Facility

Piramal Pharma Limited Expands Riverview, Michigan, Facility
areadevelopment.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from areadevelopment.com Daily Mail and Mail on Sunday newspapers.

United statesPeter deyoungApis hpapisPiramal pharma solutionsPiramal pharma limited solutionsPiramal pharma limitedPharma solutionsActive pharmaceuticalPharma solution riverviewNorth americaஒன்றுபட்டது மாநிலங்களில்பீட்டர் டியூன்பிரமல் பார்மா தீர்வுகள்பிரமல் பார்மா வரையறுக்கப்பட்டவை தீர்வுகள்பிரமல் பார்மா வரையறுக்கப்பட்டவைபார்மா தீர்வுகள்